3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
23
Neoplasm Metastasis
11
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Neoplasms
3
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Pancreatic Neoplasms
2
Glioblastoma
2
Urogenital Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Squamous Cell
1
Metastatic Castration-Resistant Prostate Cancer
1
Melanoma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Hormone Receptor Positive Breast Cancer
1
Head and Neck Neoplasms
1
Glioma
1
Ependymoma
1
Interventions
Pemetrexed
15
Cisplatin
13
pembrolizumab
6
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cediranib
3
Radiotherapy
3
Gemcitabine
3
Carboplatin
3
amatuximab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Everolimus
2
Drug Therapy
2
Cyclophosphamide
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tremelimumab
1
sodium thiosulfate
1
sargramostim
1
nintedanib
1
napabucasin
1
methoxyamine
1
liposomal doxorubicin
1
incomplete Freund's adjuvant
1
fresolimumab
1
durvalumab
1
defactinib
1
cixutumumab
1
bintrafusp alfa protein, human
1
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma, Malignant
×
abemaciclib
×
Clear all
No trials found.